Jubilant Life shares jump 7% as Q4 net profits zooms 14-fold

The company's market valuation went up by Rs 713 crore to Rs 11,516.03 crore

Jubilant Life Sciences
Jubilant Life Sciences
Press Trust of India New Delhi
Last Updated : May 24 2017 | 4:58 PM IST
Shares of Jubilant Life Sciences, on Wednesday, soared 7 per cent after the company's consolidated net profit zoomed nearly 14-fold for the March quarter.

The stock jumped 6.60 per cent to settle at Rs 723 on BSE. Intra-day, it surged 12.45 per cent to Rs 762.70.

At NSE, shares of the company gained 7 per cent to close at Rs 723.30.

The company's market valuation went up by Rs 713 crore to Rs 11,516.03 crore.

On the volume front, 4.67 lakh shares of the company were traded on BSE and over 32 lakh shares changed hands at NSE during the day.

Drug firm Jubilant Life Sciences yesterday said its consolidated net profit zoomed nearly 14-fold to Rs 149.03 crore for the March quarter on robust sales.

The company had posted a net profit of Rs 10.86 crore for the corresponding period of the previous fiscal, it said in a filing to BSE.

Consolidated total revenue from operations also rose to Rs 1,641.42 crore for the quarter under consideration as against Rs 1,515.83 crore for the same period a year ago.

For the fiscal year ended March this year, the net profit of the company rose to Rs 574.62 crore as against Rs 386.82 crore a year ago.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 24 2017 | 4:58 PM IST

Next Story